Clinical Trials Logo

Menstruation clinical trials

View clinical trials related to Menstruation.

Filter by:

NCT ID: NCT04196595 Recruiting - Infertility Clinical Trials

Apple Women's Health Study

Start date: November 14, 2019
Phase:
Study type: Observational

This is an observational longitudinal study to advance the understanding of menstrual cycle and gynecologic health conditions including PCOS, infertility and breast cancer.The study will be hosted within the Research app(available on App Store), which allows a user to find, enroll, and participate in Apple-supported health-related research studies.

NCT ID: NCT04085835 Not yet recruiting - Menstruation Clinical Trials

Evolution of Menstruation

EVOMENS
Start date: December 1, 2019
Phase:
Study type: Observational

This study examines gene expression and gene regulation in the uterine lining during menses in women, for evolutionary comparison with other primates which do or do not menstruate. Samples will be obtained by non-invasive collection of menstrual fluid from healthy donors.

NCT ID: NCT03478371 Completed - Menstruation Clinical Trials

In-use Study of Four Different Tampons

Start date: January 16, 2018
Phase: N/A
Study type: Interventional

This study will evaluate the impact on vaginal health of four different tampons using gynecologic assessment and subjective assessment of comfort during in-use conditions

NCT ID: NCT03218059 Not yet recruiting - Menstruation Clinical Trials

Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy

Start date: July 15, 2017
Phase: N/A
Study type: Interventional

Cesarean scar pregnancy (CSP)is one of the more serious complications of pregnancies that occur after a prior cesarean delivery. No clinical guidelines have been issued for the management of CSP. More than 30 treatment methods are reported to be used in managing CSP. However, which management can achieve better clinical effects remains unknown. Therefore, this prospective study is designed to compare the outcome between MTX + transvaginal surgery and UAE + D&C in the treatment of CSP.

NCT ID: NCT02933190 Not yet recruiting - Clinical trials for Magnetic Resonance Imaging

Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy

Start date: November 2016
Phase: N/A
Study type: Interventional

To investigate the fertility in patients after treatment by transvaginal surgery or uterine artery embolization combined with uterine curettage

NCT ID: NCT02829957 Completed - Clinical trials for Venous Thromboembolism

RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

(RAMBLE)
Start date: September 2016
Phase: Phase 2/Phase 3
Study type: Interventional

A large proportion of women with menstruating potential with newly diagnosed VTE or atrial fibrillation, treated with apixaban will have less menstrual blood loss than patients randomized to rivaroxaban.

NCT ID: NCT02311478 Completed - Menstrual Cycle Clinical Trials

Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users

TRIBE
Start date: December 2014
Phase: N/A
Study type: Interventional

This study aims to use validated tools as well as new technology to examine changes in bleeding patterns among women who are initiating the copper T380A IUD.

NCT ID: NCT00397202 Completed - Menstruation Clinical Trials

FLOW-Finding Lasting Options for Women

Start date: November 2006
Phase: N/A
Study type: Interventional

1. Purpose: To compare the use of the menstrual cup "The DivaCupTM " to a menstrual strategy using tampons as the primary method of menstrual flow management using indicators of user-satisfaction, urinary tract infection, vaginal irritation, cost and waste. 2. Hypothesis: The "The DivaCupTM" will have similar rates of user-satisfaction, urinary tract infection, and vaginal irritation as a menstrual strategy using tampons as the primary method of menstrual flow management but will likely be more reasonable in terms of cost and will generate less waste.